Increased plasma S-adenosylhomocysteine-accelerated atherosclerosis is associated with epigenetic regulation of endoplasmic reticulum stress in apoE-/- mice

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 35, Issue 1, 2016, Pages 60-70

  Xiao, Yunjun ^a,b   Huang, Wei ^a   Zhang, Jinzhou ^a   Peng, Chaoqiong ^a   Xia, Min ^b   Ling, Wenhua ^b  

^a SHENZHEN CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^b SUN YAT SEN UNIVERSITY   (China)

Author keywords

Atherosclerosis; endoplasmic reticulum stress; epigenenomics; S adenosylhomocysteine

Indexed keywords

ADENOSINE DIALDEHYDE; APOLIPOPROTEIN E; GLUCOSE REGULATED PROTEIN 78; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HISTONE METHYLTRANSFERASE; MESSENGER RNA; S ADENOSYLHOMOCYSTEINE; SHORT HAIRPIN RNA; TRIACYLGLYCEROL; ADENOSINE; ADENOSYLHOMOCYSTEINASE; CCAAT ENHANCER BINDING PROTEIN; CEBPA PROTEIN, MOUSE; ENZYME INHIBITOR; HEAT SHOCK PROTEIN; HISTONE; HISTONE LYSINE METHYLTRANSFERASE; MOLECULAR CHAPERONE GRP78; PERIODATE-OXIDIZED ADENOSINE; SMALL INTERFERING RNA;

AMINO ACID BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA SINUS; ARTICLE; ATHEROSCLEROSIS; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CHROMATIN IMMUNOPRECIPITATION; COMPARATIVE STUDY; CONTROLLED STUDY; ENDOPLASMIC RETICULUM STRESS; EPIGENETICS; ERYTHROCYTE; FOOD INTAKE; HISTONE METHYLATION; IMMUNOFLUORESCENCE TEST; IMMUNOHISTOCHEMISTRY; LUCIFERASE ASSAY; MACROPHAGE; MOUSE; NONHUMAN; PROMOTER REGION; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY MECHANISM; RNA METHYLATION; SUPPLEMENTATION; TRIACYLGLYCEROL BLOOD LEVEL; WESTERN BLOTTING; ANALOGS AND DERIVATIVES; ANIMAL; ANTAGONISTS AND INHIBITORS; AORTA DISEASE; ATHEROSCLEROTIC PLAQUE; BINDING SITE; BLOOD; C57BL MOUSE; CELL LINE; DEFICIENCY; DISEASE MODEL; ENDOPLASMIC RETICULUM; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETIC EPIGENESIS; GENETICS; KNOCKOUT MOUSE; MALE; METABOLISM; METHYLATION; PATHOLOGY; RNA INTERFERENCE; TIME; UPREGULATION;

ADENOSINE; ADENOSYLHOMOCYSTEINASE; ANIMALS; AORTIC DISEASES; APOLIPOPROTEINS E; ATHEROSCLEROSIS; BINDING SITES; CCAAT-ENHANCER-BINDING PROTEINS; CELL LINE; DISEASE MODELS, ANIMAL; ENDOPLASMIC RETICULUM; ENDOPLASMIC RETICULUM STRESS; ENZYME INHIBITORS; EPIGENESIS, GENETIC; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HEAT-SHOCK PROTEINS; HISTONE-LYSINE N-METHYLTRANSFERASE; HISTONES; MALE; METHYLATION; MICE, INBRED C57BL; MICE, KNOCKOUT; PLAQUE, ATHEROSCLEROTIC; PROMOTER REGIONS, GENETIC; RNA INTERFERENCE; RNA, SMALL INTERFERING; S-ADENOSYLHOMOCYSTEINE; TIME FACTORS; UP-REGULATION;

EID: 84920272153     PISSN: 10795642     EISSN: 15244636     Source Type: Journal    
DOI: 10.1161/ATVBAHA.114.303817     Document Type: Article

References (53)

1. Clarke R, Daly L, Robinson K, Naughten E, Cahalane S, Fowler B, Graham I. Hyperhomocysteinemia: an independent risk factor for vascular disease. N Engl J Med. 1991;324:1149-1155.
2. Ebbing M, Bleie Ø, Ueland PM, Nordrehaug JE, Nilsen DW, Vollset SE, Refsum H, Pedersen EK, Nygård O. Mortality and cardiovascular events in patients treated with homocysteine-lowering B vitamins after coronary angiography: a randomized controlled trial. JAMA. 2008;300:795-804.
3. Lonn E, Yusuf S, Arnold MJ, Sheridan P, Pogue J, Micks M, McQueen MJ, Probstfeld J, Fodor G, Held C, Genest J Jr; Heart Outcomes Prevention Evaluation (HOPE) 2 Investigators. Homocysteine lowering with folic acid and B vitamins in vascular disease. N Engl J Med. 2006;354:1567-1577.
4. Loscalzo J. Homocysteine trials-clear outcomes for complex reasons. N Engl J Med. 2006;354:1629-1632.
5. Kerins DM, Koury MJ, Capdevila A, Rana S, Wagner C. Plasma S-adenosylhomocysteine is a more sensitive indicator of cardiovascular disease than plasma homocysteine. Am J Clin Nutr. 2001;74:723-729.
6. Wagner C, Koury MJ. S-Adenosylhomocysteine: a better indicator of vascular disease than homocysteine? Am J Clin Nutr. 2007;86:1581-1585.
7. Xiao Y, Zhang Y, Wang M, Li X, Su D, Qiu J, Li D, Yang Y, Xia M, Ling W. Plasma S-adenosylhomocysteine is associated with the risk of cardiovascular events in patients undergoing coronary angiography: a cohort study. Am J Clin Nutr. 2013;98:1162-1169.
8. Liu C, Wang Q, Guo H, Xia M, Yuan Q, Hu Y, Zhu H, Hou M, Ma J, Tang Z, Ling W. Plasma S-adenosylhomocysteine is a better biomarker of atherosclerosis than homocysteine in apolipoprotein E-defcient mice fed high dietary methionine. J Nutr. 2008;138:311-315.
9. Luo X, Xiao Y, Song F, Yang Y, Xia M, Ling W. Increased plasma S-adenosyl-homocysteine levels induce the proliferation and migration of VSMCs through an oxidative stress-ERK1/2 pathway in apoE(-/-) mice. Cardiovasc Res. 2012;95:241-250.
10. Lusis AJ. Atherosclerosis. Nature. 2000;407:233-241.
11. Hotamisligil GS. Endoplasmic reticulum stress and atherosclerosis. Nat Med. 2010;16:396-399.
12. Hotamisligil GS. Endoplasmic reticulum stress and the infammatory basis of metabolic disease. Cell. 2010;140:900-917.
13. Zhou J, Werstuck GH, Lhoták S, de Koning AB, Sood SK, Hossain GS, Møller J, Ritskes-Hoitinga M, Falk E, Dayal S, Lentz SR, Austin RC. Association of multiple cellular stress pathways with accelerated atherosclerosis in hyperhomocysteinemic apolipoprotein E-defcient mice. Circulation. 2004;110:207-213.
14. Hossain GS, van Thienen JV, Werstuck GH, Zhou J, Sood SK, Dickhout JG, de Koning AB, Tang D, Wu D, Falk E, Poddar R, Jacobsen DW, Zhang K, Kaufman RJ, Austin RC. TDAG51 is induced by homocysteine, promotes detachment-mediated programmed cell death, and contributes to the cevelopment of atherosclerosis in hyperhomocysteinemia. J Biol Chem. 2003;278:30317-30327.
15. James SJ, Melnyk S, Pogribna M, Pogribny IP, Caudill MA. Elevation in S-adenosylhomocysteine and DNA hypomethylation: potential epigen-etic mechanism for homocysteine-related pathology. J Nutr. 2002;132(8 suppl):2361S-2366S.
16. Stipanuk MH. Sulfur amino acid metabolism: pathways for production and removal of homocysteine and cysteine. Annu Rev Nutr. 2004;24:539-577.
17. Bhaumik SR, Smith E, Shilatifard A. Covalent modifcations of histones during development and disease pathogenesis. Nat Struct Mol Biol. 2007;14:1008-1016.
18. Matouk CC, Marsden PA. Epigenetic regulation of vascular endothelial gene expression. Circ Res. 2008;102:873-887.
19. Bernstein BE, Meissner A, Lander ES. The mammalian epigenome. Cell. 2007;128:669-681.
20. Castro R, Rivera I, Struys EA, Jansen EE, Ravasco P, Camilo ME, Blom HJ, Jakobs C, Tavares de Almeida I. Increased homocysteine and S-adenosylhomocysteine concentrations and DNA hypomethylation in vascular disease. Clin Chem. 2003;49:1292-1296.
21. Wang H, Yoshizumi M, Lai K, Tsai JC, Perrella MA, Haber E, Lee ME. Inhibition of growth and p21ras methylation in vascular endothelial cells by homocysteine but not cysteine. J Biol Chem. 1997;272:25380-25385.
22. Ara AI, Xia M, Ramani K, Mato JM, Lu SC. S-adenosylmethionine inhibits lipopolysaccharide-induced gene expression via modulation of histone methylation. Hepatology. 2008;47:1655-1666.
23. Esfandiari F, Medici V, Wong DH, Jose S, Dolatshahi M, Quinlivan E, Dayal S, Lentz SR, Tsukamoto H, Zhang YH, French SW, Halsted CH. Epigenetic regulation of hepatic endoplasmic reticulum stress pathways in the ethanol-fed cystathionine beta synthase-defcient mouse. Hepatology. 2010;51:932-941.
24. Jove R, Manley JL. Transcription initiation by RNA polymerase II is inhibited by S-adenosylhomocysteine. Proc Natl Acad Sci USA. 1982;79:5842-5846.
25. Hermes M, Osswald H, Mattar J, Kloor D. Infuence of an altered methyla-tion potential on mRNA methylation and gene expression in HepG2 cells. Exp Cell Res. 2004;294:325-334.
26. Erbay E, Babaev VR, Mayers JR, Makowski L, Charles KN, Snitow ME, Fazio S, Wiest MM, Watkins SM, Linton MF, Hotamisligil GS. Reducing endoplasmic reticulum stress through a macrophage lipid chaperone alleviates atherosclerosis. Nat Med. 2009;15:1383-1391.
27. Hermes M, Geisler H, Osswald H, Riehle R, Kloor D. Alterations in S-adenosylhomocysteine metabolism decrease O6-methylguanine DNA methyltransferase gene expression without affecting promoter methyla-tion. Biochem Pharmacol. 2008;75:2100-2111.
28. Lee JK, Kim KC. DZNep, inhibitor of S-adenosylhomocysteine hydro-lase, down-regulates expression of SETDB1 H3K9me3 HMTase in human lung cancer cells. Biochem Biophys Res Commun. 2013;438:647-652.
29. Barroso M, Florindo C, Kalwa H, Silva Z, Turanov AA, Carlson BA, de Almeida IT, Blom HJ, Gladyshev VN, Hatfeld DL, Michel T, Castro R, Loscalzo J, Handy DE. Inhibition of cellular methyltransferases promotes endothelial cell activation by suppressing glutathione peroxidase 1 protein expression. J Biol Chem. 2014;289:15350-15362.
30. Ueland PM, Aarbakke J, Bessesen A. Characterization of S-adenosylhomocysteine binding to isolated rat hepatocytes and purifed rat liver plasma membranes. Effect of analogues of S-adenosylhomocysteine. Mol Pharmacol. 1982;21:108-113.
31. Ngo S, Li X, O'Neill R, Bhoothpur C, Gluckman P, Sheppard A. Elevated S-adenosylhomocysteine alters adipocyte functionality with corresponding changes in gene expression and associated epigenetic marks. Diabetes. 2014;63:2273-2283.
32. Brattström L, Wilcken DE. Homocysteine and cardiovascular disease: cause or effect? Am J Clin Nutr. 2000;72:315-323.
33. Ueland PM, Refsum H, Beresford SA, Vollset SE. The controversy over homocysteine and cardiovascular risk. Am J Clin Nutr. 2000;72:324-332.
34. Hofmann MA, Lalla E, Lu Y, Gleason MR, Wolf BM, Tanji N, Ferran LJ Jr, Kohl B, Rao V, Kisiel W, Stern DM, Schmidt AM. Hyperhomocysteinemia enhances vascular infammation and accelerates atherosclerosis in a murine model. J Clin Invest. 2001;107:675-683.
35. Wang H, Jiang X, Yang F, Gaubatz JW, Ma L, Magera MJ, Yang X, Berger PB, Durante W, Pownall HJ, Schafer AI. Hyperhomocysteinemia accelerates atherosclerosis in cystathionine beta-synthase and apolipoprotein E double knock-out mice with and without dietary perturbation. Blood. 2003;101:3901-3907.
36. Zhou J, Møller J, Danielsen CC, Bentzon J, Ravn HB, Austin RC, Falk E. Dietary supplementation with methionine and homocysteine promotes early atherosclerosis but not plaque rupture in ApoE-defcient mice. Arterioscler Thromb Vasc Biol. 2001;21:1470-1476.
37. Troen AM, Lutgens E, Smith DE, Rosenberg IH, Selhub J. The ath-erogenic effect of excess methionine intake. Proc Natl Acad Sci USA. 2003;100:15089-15094.
38. Wilson KM, McCaw RB, Leo L, Arning E, Lhoták S, Bottiglieri T, Austin RC, Lentz SR. Prothrombotic effects of hyperhomocysteinemia and hypercholesterolemia in ApoE-defcient mice. Arterioscler Thromb Vasc Biol. 2007;27:233-240.
39. Lu SC, Chen YJ, Chang PY. Letter to the editor: Is homocysteine the culprit molecule in vascular diseases or just a bystander? Am J Physiol Cell Physiol. 2010;299:C873; author reply C874.
40. Dayal S, Bottiglieri T, Arning E, Maeda N, Malinow MR, Sigmund CD, Heistad DD, Faraci FM, Lentz SR. Endothelial dysfunction and elevation of S-adenosylhomocysteine in cystathionine beta-synthase-defcient mice. Circ Res. 2001;88:1203-1209.
41. De Vriese AS, Blom HJ, Heil SG, Mortier S, Kluijtmans LA, Van de Voorde J, Lameire NH. Endothelium-derived hyperpolarizing factor-mediated renal vasodilatory response is impaired during acute and chronic hyperhomocysteinemia. Circulation. 2004;109:2331-2336.
42. Valli A, Carrero JJ, Qureshi AR, Garibotto G, Bárány P, Axelsson J, Lindholm B, Stenvinkel P, Anderstam B, Suliman ME. Elevated serum levels of S-adenosylhomocysteine, but not homocysteine, are associated with cardiovascular disease in stage 5 chronic kidney disease patients. Clin Chim Acta. 2008;395:106-110.
43. Sipkens JA, Hahn NE, Blom HJ, Lougheed SM, Stehouwer CD, Rauwerda JA, Krijnen PA, van Hinsbergh VW, Niessen HW. S-Adenosylhomocysteine induces apoptosis and phosphatidylserine exposure in endothelial cells independent of homocysteine. Atherosclerosis. 2012;221:48-54.
44. Werstuck GH, Lentz SR, Dayal S, Hossain GS, Sood SK, Shi YY, Zhou J, Maeda N, Krisans SK, Malinow MR, Austin RC. Homocysteine-induced endoplasmic reticulum stress causes dysregulation of the cholesterol and triglyceride biosynthetic pathways. J Clin Invest. 2001;107:1263-1273.
45. Zhang C, Cai Y, Adachi MT, Oshiro S, Aso T, Kaufman RJ, Kitajima S. Homocysteine induces programmed cell death in human vascular endothe-lial cells through activation of the unfolded protein response. J Biol Chem. 2001;276:35867-35874.
46. Papatheodorou L, Weiss N. Vascular oxidant stress and infammation in hyperhomocysteinemia. Antioxid Redox Signal. 2007;9:1941-1958.
47. Castro R, Rivera I, Martins C, Struys EA, Jansen EE, Clode N, Graça LM, Blom HJ, Jakobs C, de Almeida IT. Intracellular S-adenosylhomocysteine increased levels are associated with DNA hypomethylation in HUVEC. J Mol Med (Berl). 2005;83:831-836.
48. Yi P, Melnyk S, Pogribna M, Pogribny IP, Hine RJ, James SJ. Increase in plasma homocysteine associated with parallel increases in plasma S-adenosylhomocysteine and lymphocyte DNA hypomethylation. J Biol Chem. 2000;275:29318-29323.
49. Chan GC, Fish JE, Mawji IA, Leung DD, Rachlis AC, Marsden PA. Epigenetic basis for the transcriptional hyporesponsiveness of the human inducible nitric oxide synthase gene in vascular endothelial cells. J Immunol. 2005;175:3846-3861.
50. Villeneuve LM, Reddy MA, Lanting LL, Wang M, Meng L, Natarajan R. Epigenetic histone H3 lysine 9 methylation in metabolic memory and infammatory phenotype of vascular smooth muscle cells in diabetes. Proc Natl Acad Sci USA. 2008;105:9047-9052.
51. Reddy MA, Villeneuve LM, Wang M, Lanting L, Natarajan R. Role of the lysine-specifc demethylase 1 in the proinfammatory phe-notype of vascular smooth muscle cells of diabetic mice. Circ Res. 2008;103:615-623.
52. Radomski N, Kaufmann C, Dreyer C. Nuclear accumulation of S-adenosylhomocysteine hydrolase in transcriptionally active cells during development of Xenopus laevis. Mol Biol Cell. 1999;10:4283-4298.
53. Radomski N, Barreto G, Kaufmann C, Yokoska J, Mizumoto K, Dreyer C. Interaction of S-adenosylhomocysteine hydrolase of Xenopus laevis with mRNA(guanine-7-)methyltransferase: implication on its nuclear compart-mentalisation and on cap methylation of hnRNA. Biochim Biophys Acta. 2002;1590:93-102.